- The Flexibility Papers, No. 1: First Principles for a Rare Disease Framework October 29, 2026
- The PEPTIDE-L Wave Reaches HHS: Enforcement Discretion … Not the Finish Line October 28, 2026
- Six-Month Window: DOJ and HHS Launch Healthcare FCA Self-Disclosure Pilot October 27, 2026
- If You Change It, FDA Will Come: What the O.N. Diagnostics Warning Letter Means for SaMD Modifications October 26, 2026
- DOJ’s New Whistleblower Program: Fast Cash for Fraud Tips October 23, 2026
- Big Molecule Watch Blog
- Bloomberg BNA Health Care Blog
- Drug and Device Law Blog
- Eye on FDA
- FDA Matters
- Harvard Law Bill of Health
- IN VIVO Blog
- Internet Drug News.com
- Lachman Consultants Blog
- Medical Devices Today
- Orange Book Blog
- The Orange Book Insights Blog
- Pharma IQ
- Pharmalot
- SCOTUS Blog
- The Volokh Conspiracy
- WLF Legal Pulse
- Advertising and Promotion (Federal Trade Commission)
- Advertising and Promotion (OPDP)
- Animal Drugs and Feeds
- Biosimilars
- Cannabis
- cGMP Compliance
- Consumer Product Safety Commission
- Controlled Substances
- Cosmetics
- COVID19
- Current Affairs
- Dietary Supplements
- Drug Development
- Drug Enforcement Administration
- Enforcement
- FDA News
- Foods
- Foods and Dietary Supplements
- Fraud and Abuse
- Government Pricing
- Hatch-Waxman
- Health Care
- Health Privacy
- Import/Export
- In Vitro Diagnostic Devices
- Jobs
- Medical Devices
- Miscellaneous
- Orphan Drugs
- OTC Drugs and Cosmetics
- Prescription Drugs and Biologics
- Product Jurisdiction and Combination Products
- Reimbursement
- Tissue Products
- Tobacco
- Uncategorized
New CPSC Chairman is Sworn In
July 10, 2009The Consumer Products Safety Commission (“CPSC”) yesterday announced that former South Carolina State Superintendent of Education Inez Moore Tenenbaum has been sworn in as the ninth CPSC Chairman. We previously reported on her nomination and President Obama’s plans to expand the CPSC from the current three Commissioners to five Commissioners. Chairman Tenenbaum reportedly plans to focus on three major areas: accessibility and transparency to parents and consumers; education and advocacy; and enforcement.
Categories: Miscellaneous
Search FDA Law Blog
Subscribe
Latest Tweets
Tweets by @fdalawblogAwards & Honors
- Best Lawyers in America® – 2026
- Ranked in Chambers USA – 2025
- The Flexibility Papers, No. 1: First Principles for a Rare Disease Framework October 29, 2026
- The PEPTIDE-L Wave Reaches HHS: Enforcement Discretion … Not the Finish Line October 28, 2026
- Six-Month Window: DOJ and HHS Launch Healthcare FCA Self-Disclosure Pilot October 27, 2026
- If You Change It, FDA Will Come: What the O.N. Diagnostics Warning Letter Means for SaMD Modifications October 26, 2026
- DOJ’s New Whistleblower Program: Fast Cash for Fraud Tips October 23, 2026
- Big Molecule Watch Blog
- Bloomberg BNA Health Care Blog
- Drug and Device Law Blog
- Eye on FDA
- FDA Matters
- Harvard Law Bill of Health
- IN VIVO Blog
- Internet Drug News.com
- Lachman Consultants Blog
- Medical Devices Today
- Orange Book Blog
- The Orange Book Insights Blog
- Pharma IQ
- Pharmalot
- SCOTUS Blog
- The Volokh Conspiracy
- WLF Legal Pulse
- Advertising and Promotion (Federal Trade Commission)
- Advertising and Promotion (OPDP)
- Animal Drugs and Feeds
- Biosimilars
- Cannabis
- cGMP Compliance
- Consumer Product Safety Commission
- Controlled Substances
- Cosmetics
- COVID19
- Current Affairs
- Dietary Supplements
- Drug Development
- Drug Enforcement Administration
- Enforcement
- FDA News
- Foods
- Foods and Dietary Supplements
- Fraud and Abuse
- Government Pricing
- Hatch-Waxman
- Health Care
- Health Privacy
- Import/Export
- In Vitro Diagnostic Devices
- Jobs
- Medical Devices
- Miscellaneous
- Orphan Drugs
- OTC Drugs and Cosmetics
- Prescription Drugs and Biologics
- Product Jurisdiction and Combination Products
- Reimbursement
- Tissue Products
- Tobacco
- Uncategorized